0ACT Stock Overview
Develops, produces, and trades chemical products in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 3/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
No risks detected for 0ACT from our risk checks.
My Notes
Capture your thoughts, links and company narrative
AlzChem Group AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €59.80 |
| 52 Week High | €64.60 |
| 52 Week Low | €22.60 |
| Beta | 0.96 |
| 1 Month Change | 4.03% |
| 3 Month Change | 46.93% |
| 1 Year Change | 127.38% |
| 3 Year Change | 145.46% |
| 5 Year Change | 187.50% |
| Change since IPO | 191.25% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0ACT | GB Chemicals | GB Market | |
|---|---|---|---|
| 7D | -0.3% | -2.0% | -1.4% |
| 1Y | 127.4% | -24.0% | 4.6% |
Return vs Industry: 0ACT exceeded the UK Chemicals industry which returned -23.1% over the past year.
Return vs Market: 0ACT exceeded the UK Market which returned 17.5% over the past year.
Price Volatility
| 0ACT volatility | |
|---|---|
| 0ACT Average Weekly Movement | 6.3% |
| Chemicals Industry Average Movement | 5.8% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in GB Market | 10.3% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0ACT has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: 0ACT's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1908 | 1,607 | Andreas Niedermaier | www.alzchem.com |
AlzChem Group AG, together with its subsidiaries, develops, produces, and trades chemical products in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. It operates through three segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding. The company offers dietary supplements under the Creapure and Alipure brands; preparation of guanidinoacetic acid as a nutritional feed additives under the Creamino brand; creatine dietary supplements under the LIVADUR brand; products for pharmaceuticals under the Bioselect brand; curing agents, including accelerators for use in adhesives, powder coatings, printed circuit boards, and composites under the DYHARD name; and silicon nitride for ceramics, and electronics and solar applications under the SILZOT brand.
AlzChem Group AG Fundamentals Summary
| 0ACT fundamental statistics | |
|---|---|
| Market cap | €590.23m |
| Earnings (TTM) | €50.10m |
| Revenue (TTM) | €563.55m |
11.8x
P/E Ratio1.0x
P/S RatioIs 0ACT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0ACT income statement (TTM) | |
|---|---|
| Revenue | €563.55m |
| Cost of Revenue | €214.74m |
| Gross Profit | €348.81m |
| Other Expenses | €298.71m |
| Earnings | €50.10m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 28, 2025
| Earnings per share (EPS) | 4.92 |
| Gross Margin | 61.90% |
| Net Profit Margin | 8.89% |
| Debt/Equity Ratio | 0% |
How did 0ACT perform over the long term?
See historical performance and comparisonDividends
2.1%
Current Dividend Yield24%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/17 07:51 |
| End of Day Share Price | 2024/12/17 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
AlzChem Group AG is covered by 8 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Laura Lopez Pineda | Baader Helvea Equity Research |
| Konstantin Wiechert | Baader Helvea Equity Research |
| Knut Woller | Baader Helvea Equity Research |